Yoshiro Okubo Selected Research

Ketamine

11/2021

A positron emission tomography study of the serotonin1B receptor effect of electroconvulsive therapy for severe major depressive episodes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshiro Okubo Research Topics

Disease

30	Schizophrenia (Dementia Praecox) 05/2022 - 01/2002
5	Major Depressive Disorder (Major Depressive Disorders) 12/2019 - 06/2010
4	Mental Disorders (Mental Disorder) 01/2023 - 08/2008
4	Pain (Aches) 01/2022 - 06/2014
4	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 01/2014
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2021 - 04/2014
3	Anhedonia 08/2020 - 08/2014
3	Psychotic Disorders (Schizoaffective Disorder) 01/2016 - 12/2002
3	Dementia (Dementias) 01/2016 - 10/2013
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2016 - 01/2014
3	Cognitive Dysfunction 08/2015 - 05/2015
2	Multiple Sclerosis 01/2022 - 12/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Narcolepsy 11/2021 - 05/2014
2	Tobacco Use Disorder (Nicotine Dependence) 01/2017 - 05/2008
2	Delirium 01/2016 - 08/2012
2	Atrophy 07/2015 - 05/2015
2	Mania (Manias) 01/2015 - 01/2014
2	Mood Disorders (Mood Disorder) 01/2014 - 05/2002
2	Hyperprolactinemia 04/2013 - 09/2010
2	Temporal Lobe Epilepsy 01/2007 - 02/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023
1	Prodromal Symptoms 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Cerebellar Diseases (Cerebellar Syndrome) 01/2022
1	Stroke (Strokes) 01/2022
1	Treatment-Resistant Depressive Disorder 11/2021
1	Back Pain (Backache) 10/2020
1	Neck Pain (Cervicalgia) 10/2020
1	Obesity 12/2019
1	Chronic Pain 11/2019
1	Frailty 11/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Substance-Related Disorders (Drug Abuse) 09/2018
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2017
1	Shock 01/2016
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2016
1	Mobility Limitation (Difficulty Walking) 09/2012
1	Catatonia 08/2012

Drug/Important Bio-Agent (IBA)

11	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 05/2022 - 01/2002
11	Antipsychotic Agents (Antipsychotics)IBA 05/2022 - 03/2004
10	Dopamine (Intropin)FDA LinkGeneric 08/2020 - 06/2004
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2009
5	blonanserinIBA 05/2022 - 04/2013
5	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2016 - 03/2004
5	FLB 457IBA 04/2013 - 01/2002
3	Modafinil (Provigil)FDA Link 11/2021 - 05/2014
3	RacloprideIBA 11/2017 - 12/2006
3	Amyloid beta-PeptidesIBA 01/2017 - 05/2015
3	florbetapirIBA 08/2015 - 05/2015
3	Amyloid (Amyloid Fibrils)IBA 07/2015 - 01/2014
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2015 - 01/2014
3	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 04/2014 - 08/2008
3	Olanzapine (Zyprexa)FDA Link 08/2012 - 06/2010
2	Tramadol (K315)FDA LinkGeneric 09/2018 - 06/2014
2	Nicotine FDA Link 01/2017 - 05/2008
2	Yi-Gan SanIBA 01/2016 - 10/2013
2	Fluvoxamine (Luvox)FDA LinkGeneric 01/2016 - 10/2013
2	MethoxyhydroxyphenylglycolIBA 01/2015 - 01/2014
2	Serotonin (5 Hydroxytryptamine)IBA 06/2014 - 06/2013
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 05/2014 - 10/2009
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014 - 04/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 08/2010 - 02/2008
2	Antidepressive Agents (Antidepressants)IBA 08/2008 - 05/2002
2	5-HT1A Serotonin ReceptorIBA 01/2007 - 03/2004
2	Protons (Proton)IBA 06/2006 - 02/2004
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	Ketamine FDA LinkGeneric 11/2021
1	5-HT1B Serotonin ReceptorIBA 11/2021
1	Dopamine D3 ReceptorsIBA 05/2021
1	naxagolideIBA 05/2021
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2021
1	TabletsIBA 01/2021
1	Bupropion (Wellbutrin)FDA LinkGeneric 12/2019
1	Therapeutic UsesIBA 01/2019
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2019
1	N-n-propylnorapomorphineIBA 11/2017
1	Opioid Receptors (Opioid Receptor)IBA 06/2014
1	Wakefulness-Promoting AgentsIBA 05/2014
1	Nortriptyline (Aventyl)FDA LinkGeneric 04/2014
1	Milnacipran (Ixel)FDA Link 06/2013
1	ProlactinIBA 04/2013
1	Hormones (Hormone)IBA 01/2013
1	A-factor (Streptomyces)IBA 04/2012
1	Indicators and Reagents (Reagents)IBA 09/2010
1	Haloperidol (Haldol)FDA LinkGeneric 09/2010
1	Sulpiride (neogama)IBA 09/2010
1	DAA 1106IBA 08/2010
1	LigandsIBA 05/2010
1	SCH 23390IBA 05/2010
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 05/2010
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2010

Therapy/Procedure

2	Activities of Daily Living (ADL) 07/2015 - 09/2012
1	Transdermal Patch 05/2022
1	Neurological Rehabilitation 12/2021
1	Polypharmacy 10/2020
1	Pain Management 11/2019
1	Wearable Electronic Devices 01/2019
1	Drug Therapy (Chemotherapy) 01/2016
1	Therapeutics 01/2016